Sylebra Capital Ltd. has recently announced that it has increased stake in MYT Netherlands Parent B.V. (NYSE:MYTE) by 12.66%. After grabbing 3.74 million shares, the institutional investor is now in possession of 0.42 million shares of the Consumer Cyclical Company. The new investment brought the stake of investor firm to 4.43% having worth around $33.36 million. Moreover, DJE Kapital AG increased its share by 36058.0 to have a control over 2.27 million shares.
MYT Netherlands Parent B.V. (MYTE) concluded trading on 01/18/23 at a closing price of $11.14, with 0.24 million shares of worth about $2.64 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -5.03% during that period and on Wednesday the price saw a gain of about 0.09%. Currently the company’s common shares owned by public are about 86.50M shares, out of which, 17.26M shares are available for trading.
Will You Miss Out On This Growth Stock Boom?
A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.
And this is just one of our
5 Best Growth Stocks To Own For 2023.
Sponsored
A deeper look into what the analysts at Wall Street are thinking about the price target of this stock provides us with the following: 9 analysts are covering the MYTE stock and their offered price forecasts bring an average price target of $15.18. Over the next 12 months, analysts forecasted that the stock’s price could jump as high as $19.53 and could fall to a lowest price of $8.31. The stock’s current price level is 29.89% above of average price target set by the analysts, while a rise to estimated low would result in loss of -34.06% for the stock. However, touching the estimated high of $19.53 would mean a gain of 42.96% for the stock.
DJE – Dividende & Substanz, DWS Concept DJE Globale Aktien, and T Rowe Price International Discov are the top 3 mutual funds which are holding stakes in MYT Netherlands Parent B.V. DJE – Dividende & Substanz is currently holding 1.12 million shares of worth totaling $9.96 million. The company recently came selling 81475.0 shares which brought its stake up to 1.32% of the company’s outstanding shares. DWS Concept DJE Globale Aktien sold 3047.0 shares, after which its hold over company’s outstanding shares shrunk to 1.22%, leaving 1.03 million shares with the mutual fund that have a worth of about $9.17 million. T Rowe Price International Discov, after buying 1.01 million shares, have now control over 1.20% of the stake in the company. It holds 0.0 shares of worth $9.03 million.
MYT Netherlands Parent B.V. (NYSE: MYTE) started trading at $11.11, below -$0.02 from concluding price of the previous day. However, the stock later moved at a day high price of 11.78, or with a gain of 0.09%. Stock saw a price change of 6.30% in past 5 days and over the past one month there was a price change of 25.31%. Year-to-date (YTD), MYTE shares are showing a performance of 25.03% which decreased to -38.04% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $8.29 but also hit the highest price of $20.00 during that period. The average intraday trading volume for MYT Netherlands Parent B.V. shares is 86.06K. The stock is currently trading 16.16% above its 20-day simple moving average (SMA20), while that difference is up 12.06% for SMA50 and it goes to -2.53% lower than SMA200.
Sylebra Capital Ltd. acquired 3.74 million shares of MYT Netherlands Parent B.V. having value of about $33.36 million. Data submitted at the U.S SEC by Sylebra Capital Ltd. revealed that the firm now holds 0.42 million shares in the company valued at close to $4686029.86, or have control over 12.66% stake in the company. MYT Netherlands Parent B.V. (NYSE: MYTE) currently have 86.50M outstanding shares and institutions hold larger chunk of about 21.70% of that. Holding of mutual funds in the company is about 12.35% while other institutional holders and individual stake holders have control over 9.41% and — of the stake respectively.
The stock has a current market capitalization of $946.90M. It has posted earnings per share of -$0.06 in the same period. It has Quick Ratio of 0.90 while making debt-to-equity ratio of 0.10. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for MYTE, volatility over the week remained 5.39% while standing at 6.00% over the month.
Analysts are in expectations that MYT Netherlands Parent B.V. (MYTE) stock would likely to be making an EPS of $0 in the current quarter, while forecast for next quarter EPS is $0 and it is $0 for next year. For the current quarter EPS, analysts have given the company a lowest target $0 which is $0 at the higher side of the target for the same. Stock’s fiscal year EPS is expected to rise by 78.30% while it is estimated to increase by 17.90% in next year.
Analysts at 9 brokerage firms have issued recommendations for the MYT Netherlands Parent B.V. (MYTE)’s stock and average of those rates the stock at a “Strong Buy” and assign it a score of 1.90. Out of those 9 Wall Street analysts, 8 recommended a “Buy” rating, while 1 were in favor recommending the stock as a “Hold” and 0 analyst recommended the stock as “Sell”.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Morgan Stanley on April 12, 2022 offering an Equal-weight rating for the stock and assigned a target price of $14 to it. Coverage by UBS stated MYT Netherlands Parent B.V. (MYTE) stock as a Buy in their note to investors on March 24, 2022, suggesting a price target of $19 for the stock. On January 18, 2022, Societe Generale Upgrade their recommendations, while on December 02, 2021, UBS Resumed their ratings for the stock with a price target of $30. Stock get a Buy rating from BofA Securities on October 14, 2021.
